Advanced Medicine Partners Email Formats
Biotechnology Research • 
Cary, North Carolina, United States • 21-50 Employees
Advanced Medicine Partners Email Formats
Advanced Medicine Partners uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@ampgtx.com), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@ampgtx.com | 66.7% |
{first name}{last name} | johndoe@ampgtx.com | 29.2% |
{last name}{last name} | doedoe@ampgtx.com | 4.2% |
Key Contacts at Advanced Medicine Partners
David Greenwald
Board Of Directors
Felix Hsu
Independent Board Director
Pete Candito
Director, Operational Excellence
Matt Carter
Sr Director - Finance
Nick Mauro
Director Of Manufacturing
Austin Smith
Director
Alyne Millsap
Director, Quality Systems
Company overview
| Headquarters | 203 MacKenan Drive, Cary, North Carolina 27511, US |
| Website | |
| NAICS | 541714 |
| Keywords | Biotechnology, Manufacturing, Cgmp, AAV, Gene Therapy, Analytical Testing, Cell Therapy, Method Development, Cdmo, Genetic Medicines |
| Founded | 2023 |
| Employees | 21-50 |
About Advanced Medicine Partners
Advanced Medicine Partners’ aims to set a new standard for manufacturing and testing innovative medicines that can potentially transform the lives of patients and families. The company delivers process development, manufacturing, analytical development and testing for advanced therapy products, including gene therapies. The company has the experience and capabilities to work with multiple platforms and modalities, including adeno-associated virus (AAV), lentivirus and other delivery systems. Advanced Medicine Partners leverages one of the most experienced genetic medicines teams – at all levels, from bench to boardroom – in the industry, and its exclusive manufacturing platform consistently produces yields that are among the highest in the industry and purity profiles that push the boundaries of what’s possible. The company’s proprietary adeno-associated virus (AAV) manufacturing process minimizes process and product-related impurities and consistently generates industry-leading functional full capsid ratios and best-in-class yields. This manufacturing process prioritizes patient safety while reducing cost of goods and will strive to set the standard for what regulatory agencies expect and patients deserve. Advanced Medicine Partners brings extensive operational experience from Jaguar Gene Therapy and other biotechnology companies. The Advanced Medicine Partners team has manufactured upwards of 350 total non-GMP batches and supplied over 20 preclinical studies, including initial new drug application (IND) enabling efficacy and good laboratory practice (GLP) toxicology studies. The company distinguishes itself from CDMOs by its partnership philosophy. Traditionally, CDMO operations work independently of their clients. Advanced Medicine Partners changes that dynamic by acting as a client’s extended workbench, removing CMC activities from the critical path, and offering real-time data to help clients drive decisions and accelerate their programs.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Advanced Medicine Partners has 11 employees across 5 departments.
Departments
Number of employees
Funding Data
Explore Advanced Medicine Partners's funding history, including investment rounds, total capital raised, and key backers.
Advanced Medicine Partners Tech Stack
Discover the technologies and tools that power Advanced Medicine Partners's digital infrastructure, from frameworks to analytics platforms.
Video players
Form builders
JavaScript libraries
Video players
JavaScript libraries
JavaScript libraries
Maps
JavaScript libraries
JavaScript libraries
CDN
Font scripts
Brazil
United Arab Emirates
Spain
United Kingdom
Frequently asked questions
4.8
40,000 users
